10m
President-elect Donald Trump's choice for defense secretary in his second term, Pete Hegseth, was investigated for alleged ...
AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback